Respigen brand salbutamol inhaler is being discontinued

The factory has stopped making Respigen inhalers (Pharmacode 2272911). Other brands of salbutamol inhaler remain available.

Affected product

The factory making Respigen inhalers has been closed down. Supply has ended but there may be some stock in the supply chain.

  • Brand: Respigen
  • Chemical: Salbutamol
  • Presentation: Aerosol inhaler, 100 mcg per dose CFC free
  • Pharmacode: 2272911
  • To be delisted: 1 September 2024

Schedule listing for salbutamol inhalers(external link)

Respigen is a plain blue inhaler. SalAir is grey with some embossed writing on the front and the ventolin inhaler is blue with an embossed V on it..

Two alternative brands are available

There are two alternative brands available that have the same formulation of salbutamol and the same propellant. They are:

  • SalAir which is fully funded (Pharmacode 2404516)
  • Ventolin which is partially funded (Pharmacode 2026414).

People moving to SalAir should note that their reliever inhaler is now grey (rather than blue). 

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is. 

Sign up to our email list for regular emails about supply issues and more(external link)